Neurology
Partner With Us
Advertisement

Rare Diseases

thumb description

January 16, 2025

New XLH Guidelines Shift Primary Therapy to Burosumab

"Burosumab treatment normalized ALP serum levels in about 80% of both pediatric and adolescent cohorts, suggesting a substantial improvement of rickets in these patients," report authors of comprehensive new evidence-based recommendations for X-linked hypophosphatemia management.

Conexiant

thumb description

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

thumb description

January 14, 2025

Genetic Mutations in ANO3 Linked to Dystonia

Dysregulated Ca²⁺ signaling due to ANO3 mutations impairs K⁺ channel activation in striatal neurons, offering new insights into the pathophysiology of dystonia.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

January 07, 2025

Outcomes of Anaphylaxis vs Cardiac OHCA: New Insights

Researchers have found that out-of-hospital cardiac arrests caused by anaphylaxis are associated with better neurological outcomes and higher survival rates compared to those caused by cardiac conditions.

Conexiant